Dergiler / Kocatepe Tıp Dergisi / 2026 / Cilt: 27 Sayı: 4

BİRİNCİ BASAMAK SAĞLIK ÇALIŞANLARINDA SERVİKS KANSERİ, HPV VE HPV AŞILARINA İLİŞKİN BİLGİ DÜZEYİ, AŞI TUTUMU VE AŞI ÖNERME DAVRANIŞI: KESİTSEL ARAŞTIRMA

KNOWLEDGE OF CERVICAL CANCER AND HPV, ATTITUDES TOWARD HPV VACCINATION, AND RECOMMENDATION PRACTICES AMONG PRIMARY HEALTHCARE WORKERS: A CROSS-SECTIONAL STUDY

Gamze Dur(Afyonkarahisar Sağlık Bilimleri Üniversitesi)0000-0003-0073-4429
Ayşen Mert(Afyonkarahisar Sağlık Bilimleri Üniversitesi)0000-0002-0933-706X
Mustafa Cihat Çeliköz(Afyonkarahisar Sağlık Bilimleri Üniversitesi)0000-0001-8687-2122
Zeynep Yalçınkaya(Afyonkarahisar Merkez Toplum Sağlığı Merkezi)0000-0002-5568-7116
Yiğit Şenol(Afyonkarahisar Sağlık Bilimleri Üniversitesi)0000-0002-2220-4595
Sayfa
546–555
Yayın Tarihi
2026-10-12
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

BULGULAR: Katılımcıların %86,2’si serviks kanserinin önlenebilir olduğunu belirtirken, yalnızca %45,2’si HPV enfeksiyonunu en önemli risk etmeni olarak tanımladı.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AMAÇ: Serviks kanseri, tarama ve HPV aşılamasıyla büyük ölçüde önlenebilmektedir.
📊
Temel Bulgular & Veri:Ancak bu koruyucu uygulamaların başarısı, birinci basamakta etkin biçimde yürütülmelerine bağlıdır.
💡
Sonuç & Katkı:BULGULAR: Katılımcıların %86,2’si serviks kanserinin önlenebilir olduğunu belirtirken, yalnızca %45,2’si HPV enfeksiyonunu en önemli risk etmeni olarak tanımladı.
🔬Tür:Deneysel Tarla Denemesi
📍Kapsam:2023 Verileri
⚙️Değişkenler:Serviks Kanseri · İnsan Papilloma Virüsü · HPV aşısı

Özet

AMAÇ: Serviks kanseri, tarama ve HPV aşılamasıyla büyük ölçüde önlenebilmektedir. Ancak bu koruyucu uygulamaların başarısı, birinci basamakta etkin biçimde yürütülmelerine bağlıdır. Bu çalışmada, birinci basamak sağlık çalışanlarının serviks kanseri, insan papilloma virüsü (HPV) ve HPV aşılamasına ilişkin bilgi, farkındalık, tutum ve özbildirime dayalı davranışları değerlendirildi. GEREÇ VE YÖNTEM: Bu kesitsel çalışmada, Afyonkarahisar ilindeki Aile Sağlığı Merkezleri ve Toplum Sağlığı Merkezlerinde çalışan 305 sağlık personeline, 15 Şubat–15 Haziran 2023 tarihleri arasında yüz yüze anket uygulandı. Analizler IBM SPSS Statistics 26.0 kullanılarak yapıldı. Kategorik değişkenler ki-kare veya Fisher'ın kesin testi kullanılarak karşılaştırıldı. HPV aşısı önerme ve çocuğunu aşılatma isteği ile ilişkili etmenler çok değişkenli lojistik regresyonla değerlendirildi. İstatistiksel anlamlılık için p<0,05 eşiği kullanıldı. BULGULAR: Katılımcıların %86,2’si serviks kanserinin önlenebilir olduğunu belirtirken, yalnızca %45,2’si HPV enfeksiyonunu en önemli risk etmeni olarak tanımladı. HPV’nin serviks kanserine yol açabileceğine (%92,8) ve cinsel yolla bulaşabildiğine (%97,4) ilişkin farkındalık yüksekti; enfeksiyonun doğal seyrine ilişkin bilgi ise sınırlıydı. Özbildirime dayalı kişisel aşılanma oranları düşüktü (bivalan %3,3; kuadrivalan %10,8). Katılımcıların %65,2’si (n=199) hastalarına HPV aşısı önerdiğini, %79,3’ü (n=242) çocuğunu aşılatmaya istekli olduğunu ve %66,9’u (n=204) HPV aşıları hakkında bilgisi olduğunu bildirdi. Hekimlerde, diğer sağlık çalışanlarına göre aşı önermeye ilişkin düzeltilmiş odds oranı (aOR) 3,20 idi (%95 GA 1,63–6,29). Mesleki eğitim sırasında serviks kanseri, tedavisi ve taraması konusunda eğitim alma, hem aşı önerme (aOR 3,60; %95 GA 2,11–6,13) hem de çocuğunu aşılatma isteği (aOR 3,11; %95 GA 1,71–5,65) ile ilişkiliydi. SONUÇ: Birinci basamak sağlık çalışanlarında serviks kanseri, HPV ve HPV aşılamasına ilişkin bilgi eksiklikleri saptandı; özbildirime dayalı kişisel aşılanma oranları düşüktü. Birinci basamakta yapılandırılmış eğitimlerin güçlendirilmesi, HPV aşısı danışmanlığını ve aşı önerme uygulamalarını destekleyebilir.

Abstract

OBJECTIVE: Cervical cancer (CC) is largely preventable through screening and human papillomavirus (HPV) vaccination; successful prevention depends on effective implementation of these interventions in primary care. We evaluated primary healthcare workers’ knowledge, awareness, attitudes, and self-reported behaviors regarding CC, HPV, and HPV vaccination. MATERIAL AND METHODS: In this cross-sectional study, data were collected using face-to-face questionnaires from 305 healthcare workers at Family Health Centers and Community Health Centers in Afyonkarahisar, Türkiye, between February 15 and June 15, 2023. Analyses were performed using IBM SPSS Statistics 26.0. Categorical variables were compared using chi-square or Fisher’s exact tests. Multivariable logistic regression assessed factors associated with HPV vaccine recommendation and willingness to vaccinate one’s child. Statistical significance was defined as p<0.05. RESULTS: Although 86.2% stated that CC is preventable, only 45.2% identified HPV infection as the most important risk factor. Awareness that HPV can cause CC (92.8%) and is sexually transmitted (97.4%) was high, whereas knowledge of its natural course was limited. Self-reported personal vaccination rates were low (bivalent 3.3%; quadrivalent 10.8%). Overall, 65.2% (n=199) recommended HPV vaccination to patients, 79.3% (n=242) were willing to vaccinate their child, and 66.9% (n=204) reported having knowledge of HPV vaccines. Compared with other healthcare workers, physicians had higher odds of recommending vaccination (adjusted odds ratio [aOR] 3.20, 95% CI 1.63–6.29). Education on CC, its treatment, and screening during professional training was associated with higher adjusted odds of recommending vaccination (aOR 3.60, 95% CI 2.11–6.13) and willingness to vaccinate one’s child (aOR 3.11, 95% CI 1.71–5.65). CONCLUSIONS: Primary healthcare workers showed item-specific gaps in knowledge of CC, HPV, and HPV vaccination, alongside low self-reported personal vaccination rates. Strengthening structured education in primary care may support HPV vaccine counseling and recommendation practices.

🔖

Bu Makaleye Atıf Yap

Dur, G., Mert, A., Çeliköz, M. C., Yalçınkaya, Z., Şenol, Y. (2026). BİRİNCİ BASAMAK SAĞLIK ÇALIŞANLARINDA SERVİKS KANSERİ, HPV VE HPV AŞILARINA İLİŞKİN BİLGİ DÜZEYİ, AŞI TUTUMU VE AŞI ÖNERME DAVRANIŞI: KESİTSEL ARAŞTIRMA. Kocatepe Tıp Dergisi, Cilt: 27 Sayı: 4, 546–555. https://doi.org/10.18229/kocatepetip.1932749

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (46)

  1. Adiga D, Eswaran S, Pandey D, et al. Molecular landscape of recurrent cervical cancer. Crit Rev Oncol Hematol. 2021;157:103178.
  2. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health. 2020;8(2):191–203.
  3. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
  4. Galvão MLTC, Coimbra EC. Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects. Crit Rev Oncol Hematol. 2020;156:103111.
  5. Razavi ZS, Tajiknia V, Majidi S, et al. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. Crit Rev Oncol Hematol. 2021;157:103192.
  6. Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol. 2016;37:278–85.
  7. Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14–26.
  8. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.
  9. Asiaf A, Ahmad ST, Mohammad SO, Zargar MA. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur J Cancer Prev. 2014;23:206–24.
  10. Zhao RW, Guo ZQ, Zhang RX. Human papillomavirus infection and the malignant transformation of sinonasal inverted papilloma: A meta-analysis. J Clin Virol. 2016;79:36–43.
  11. Knör M, Tziridis K, Agaimy A, et al. Human papillomavirus (HPV) prevalence in nasal and antrochoanal polyps and association with clinical data. PLoS One. 2015;10:e0141722.
  12. Afrogheh AH, Jakobiec FA, Hammon R, et al. Evaluation for high-risk HPV in squamous cell carcinomas and precursor lesions arising in the conjunctiva and lacrimal sac. Am J Surg Pathol. 2016;40:519–28.
  13. Pathak P, Pajai S, Kesharwani H. A review on the use of the HPV vaccine in the prevention of cervical cancer. Cureus. 2022;14(9):e28710.
  14. World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017– recommendations. Vaccine. 2017;35:5753–5.
  15. Chaturvedi AK. Beyond cervical cancer: Burden of other HPV-related cancers among men and women. J Adolesc Health. 2010;46(4):20–6.
  16. Tian R, Liu J, Fan W, et al. Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells. Mol Ther Oncolytics. 2021;24:171–9.
  17. Chatterjee S, Chattopadhyay A, Samanta L, Panigrahi P. HPV and cervical cancer epidemiology – current status of HPV vaccination in India. Asian Pac J Cancer Prev. 2016;17(8):3663–73.
  18. Shapiro GK. HPV vaccination: An underused strategy for the prevention of cancer. Curr Oncol. 2022;29:3780– 92.
  19. Garland SM. The Australian experience with the human papillomavirus vaccine. Clin Ther. 2014;36:17–23.
  20. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63:1–30.
  21. Ferris D, Samakoses R, Block SL, et al. Long-term study of a quadrivalent human papillomavirus vaccine. Pediatrics. 2014;134:e657-65.
  22. Goldstone SE, Giuliano AR, Palefsky JM, et al. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: Results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2022;22:413–25.
  23. Drolet M, Benard E, Boily MC, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect Dis. 2015;15:565–80.
  24. Villa A, Patton LL, Giuliano AR, et al. Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews. J Am Dent Assoc. 2020;151:245-54.
  25. Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5(5):CD009069.
  26. World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. https://www.who.int/publications/i/item/9789240014107. Accessed: 01.04.2026.
  27. Shakurnia A, Salehpoor F, Ghafourian M, Nashibi R. Knowledge and attitudes toward HPV, cervical cancer and HPV vaccine among healthcare providers in Ahvaz, Southwest Iran. Infect Agent Cancer. 2025;20:44.
  28. Bruni L, Albero G, Serrano B, et al. Human papillomavirus and related diseases in the world. Summary report.ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2023;3(10):307.
  29. Soheili M, Keyvani H, Soheili M, Nasseri S. Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers. Med J Islam Repub Iran. 2021;35:65.
  30. Williamson AL. Recent developments in human papillomavirus (HPV) vaccinology. Viruses. 2023;15(7):1440.
  31. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(5):12–23.
  32. Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30(5):123–38.
  33. Gönenç İM, Abbas MN, Çalbayram N, Yılmaz S. A review of knowledge and attitudes of young people on cervical cancer and HPV vaccination. J Public Health (Berl). 2020;28(1):97–103.
  34. Escoffery C, Petagna C, Agnone C, et al. A systematic review of interventions to promote HPV vaccination globally. BMC Public Health. 2023;23:1262.
  35. Akova İ, Ekici Koşaroğlu N, Kılıç E. Knowledge, attitudes, and behaviours of primary health care workers regarding HPV infection and prevention: An example from Türkiye. Turkish J Fam Med Prim Care. 2023;17:407–15.
  36. Thanapprapasr D, Chittithaworn S, Lertkhachonsuk AA, Udomsubpayakul U, Wilailak S. Female hospital- based healthcare professionals’ knowledge of cervical cancer, HPV and attitudes towards HPV vaccination. Asian Pac J Cancer Prev. 2010;11(2):429–33.
  37. Özbakır Acar N, Özşahin A, Edirne T. Knowledge and attitudes of primary health care workers about cervical cancer and HPV vaccine. Pamukkale Med J. 2019;12:457–66.
  38. Nilsen K, Aasland OG, Klouman E. The HPV vaccine: Knowledge and attitudes among public health nurses and general practitioners in Northern Norway after introduction of the vaccine in the school-based vaccination programme. Scand J Prim Health Care. 2017;35:387–95.
  39. Chellapandian P, Myneni S, Ravikumar D, et al. Knowledge on cervical cancer and perceived barriers to the uptake of HPV vaccination among health professionals. BMC Womens Health. 2021;21:65.
  40. Pérez MRO, Violeta VB, del Campo AV, et al. Cross-sectional study about primary health care professionals views on the inclusion of the vaccine against human papillomavirus in the vaccine schedules. Infect Agent Cancer. 2015;10:41.
  41. Wamai RG, Ayissi CA, Oduwo GO, et al. Awareness, knowledge and beliefs about HPV, cervical cancer and HPV vaccines among nurses in Cameroon: An exploratory study. Int J Nurs Stud. 2013;50(10):1399–1406.
  42. Erbaydar N, Çilingiroğlu N, Keskin C, et al. What does human papilloma virus vaccine mean to university hospital nurses? Hacettepe Üniversitesi Hemşirelik Fakültesi Derg. 2016;3:16–27.
  43. Görkem Ü, Toğrul C, İnal HA, Salman-Özgü B, Güngör T. Knowledge and attitudes of allied health personnel in university hospital related to Human Papilloma Virus and the vaccine. Turk Hij Den Biyol Derg. 2015;72(4):303–10.
  44. Sağtaş F, Yalçın Gürsoy M. Knowledge, attitudes, and practices towards human papillomavirus (HPV) and HPV vaccination among male nurses. Int J Nurs Pract. 2024;30(4):e13228.
  45. Çift T, Korkmazer E, Temur M, et al. Assessment of knowledge and attitudes of midwives and nurses working at the hospital about human papilloma virus vaccinations. Med J Ankara Tr Res Hosp. 2019;52:49–52.
  46. Aydın M, Gül A, Çalış Z, Celik C. The impact of human papillomavirus (HPV) positivity on depression, anxiety and sexual functions in women. Kocatepe Tıp Dergisi. 2026;27(1):73-80.